🟢 MetaVia is trading 5.8% up in pre-market; catalyst remains unclear

MetaVia is trading at $1.28, up +5.79% before the open on October 27, 2026, with no confirmed company-specific catalyst.

• It closed at $1.22 on October 26, down 11.96% for that session.
• The latest located company announcement was the October 13 appointment of Sarah Browne as chief medical officer.
• Broader market indicators were mixed, and the provided index gains were modest, so they do not establish a clear explanation; the cause remains unclear.